AHA Scientific Sessions 2025 Abstract
A transformative LDL cholesterol–lowering in vivo CRISPR gene editing medicine that functionally upregulates LDLR in mice and non-human primates
Experiments in animalsInterventions
Papers by Mohammadreza Kazemian
1 result